News
22th of August 2023: Prohibition of PFAS – Evaluate, assess risks, time to act
13th of April 2023: SMEPAC Test to Measure the Tightness of Containment Systems
29th of August 2022: Computerized System Validation (CSV) – GAMP 5 Second Edition
1th of June: New ICH Q14 Guideline: Analytical procedure development
18th of February: Revision of ICH Q9 (R1) Guideline on Quality Risk Management
15th of April 2021: WHO publishes decision on setting acceptance criteria for cleaning validation
8th of January 2021: Integrated Qualification and Validation Guide
2th of December 2020: Good Manufacturing Practice (GMP)
26th of October 2020: Nitrosamines in active substances and finished medicinal products
15th of June 2020: Current trends and outlook on cleanroom requirements
12th of June 2020: Pharmaceutical procurement & supplier qualification
4th of February 2021: Vaccinations with mRNA-based medicinal products
9th of October 2020: 2nd APV Interactive Workshop on ATMP
24th of September 2020: MSC & Covid-19
24th of August 2020: FDA opens up approval process for RYONCYL™
4th of August 2020: FDA approves CAR T-cell therapy Tecartus™
17th of January 2020: BioNTech SE acquires Neon Therapeutics
9th of January 2020: New legal regulations governing the application of ATMPs
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
Evolving research has now shown that immunotherapies can be combined with one another and used to specifically target the cancer cells.
First publication date: 08/09/2023 In the book entitled Microfluidic Systems for Cancer Diagnosis, the UPV/EHU’s Microfluidics Cluster ...
Selecting and sequencing treatments in relapsed/refractory multiple myeloma involves balancing various factors due to limited historical ...
To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous ...
CRISPR Beyond Genetic Diseases When CRISPR-Cas9 was first found, and subsequently earned its discoverers a Nobel Price in 2020, the ...
The typical process for CAR-T cell therapy involves the removal of a patient's T cells, which are then engineered in a lab to incorporate ...
Cell and gene therapies (C>s) are swiftly developing within the biopharmaceutical sector. The expanding C> space is exerting substantial ...
By Ryan Chandanais, drug pipeline manager, Two Labs ...
One study discovers why CAR NK cells lose steam over time and suggests a way to rejuvenate their cancer-killing ability.
FDA decisions 2023: AstraZeneca, Viatris, Outlook and more ...
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Interview mit Matthias Hebrok, Center for Organoid Systems, Technische Universität München ...
Researchers revealed the importance of the transmission of epigenetic information through cell division for embryonic stem cells ...
T cell immunotherapies have revolutionized the treatment of many types of cancer; however, the exact mechanisms of some of these therapies ...